Elisabeth Leiderman

Officer, Decibel Therapeutics, Inc.

Companies

Autolus TherapeuticsBoard member Mar 18, 2026 to now¹
bluebird bioBoard member Oct 19, 2021 to now²
Decibel Therapeutics, Inc.Chief financial officer Feb 28, 2022 to Feb 28, 2022³
Decibel Therapeutics, Inc.Officer Feb 11, 2021 to Feb 11, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

bluebird bio BLUE0 shares⁵Jun 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 2, 2025Returned to company 1,245 shares of bluebird bio⁵
May 30, 2025U 1,112 shares of bluebird bio⁵
Nov 6, 2024Granted 24,900 shares of bluebird bio⁶
Jun 16, 2023Granted 10,790 shares of bluebird bio⁷
Oct 17, 2022Sold 1,004 shares at $6.46 of bluebird bio⁸
Jun 22, 2022Granted 3,109 shares of bluebird bio⁹
Nov 11, 2021Other 9,361 shares of bluebird bio¹⁰
Oct 15, 2021Granted 4,663 shares of bluebird bio¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAutolus Therapeutics, Board member
2
SEC EDGARbluebird bio, Board member
3
SEC EDGARDecibel Therapeutics, Inc., Chief financial officer
4
SEC EDGARDecibel Therapeutics, Inc., Officer
5
SEC EDGARbluebird bio shares after the filing of Jun 2, 2025
6
SEC EDGARForm 4 filed Nov 8, 2024
7
SEC EDGARForm 4 filed Jun 20, 2023
8
SEC EDGARForm 4 filed Mar 9, 2023
9
SEC EDGARForm 4 filed Jun 23, 2022
10
SEC EDGARForm 4 filed Nov 16, 2021
11
SEC EDGARForm 4 filed Oct 19, 2021